Anonymising and sharing individual patient data
Open Access
- 20 March 2015
- Vol. 350 (mar20 1), h1139
- https://doi.org/10.1136/bmj.h1139
Abstract
There is a strong movement to share individual patient data for secondary purposes, particularly for research. A major obstacle to broad data sharing has been the concern for patient privacy. One of the methods for protecting the privacy of patients in accordance with privacy laws and regulations is to anonymise the data before it is shared. This article describes the key concepts and principles for anonymising health data while ensuring it remains suitable for meaningful analysis.This publication has 24 references indexed in Scilit:
- Evaluating the risk of patient re-identification from adverse drug event reportsBMC Medical Informatics and Decision Making, 2013
- Open Clinical Trial Data for All? A View from RegulatorsPLoS Medicine, 2012
- De-identification Methods for Open Health Data: The Case of the Heritage Health Prize Claims DatasetJournal of Medical Internet Research, 2012
- A Systematic Review of Re-Identification Attacks on Health DataPLOS ONE, 2011
- Why we need easy access to all data from all clinical trials and how to accomplish itTrials, 2011
- A Model for Dissemination and Independent Analysis of Industry DataJAMA, 2011
- The International Stroke Trial databaseTrials, 2011
- Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewersTrials, 2010
- A Globally Optimal k-Anonymity Method for the De-Identification of Health DataJournal of the American Medical Informatics Association, 2009
- Written informed consent and selection bias in observational studies using medical records: systematic reviewBMJ, 2009